QQ客服 官方微博 反馈留言

	Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor- by inhibiting the nuclear factor-kappa B signaling pathway
	Zhu, Jing; Xin, Ying; Liu, Xiaoliang; Wang, Ying; Liu, Ying
刊名	EXPERIMENTAL AND THERAPEUTIC MEDICINE
	2018
卷号	15期号:4
关键词	non-small cell lung cancer nuclear factor-kappa B tumor necrosis factor-alpha nimotuzumab drug resistance
ISSN号	1792-0981
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3536605
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Zhu, Jing,Xin, Ying,Liu, Xiaoliang,et al. Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor- by inhibiting the nuclear factor-kappa B signaling pathway[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2018,15(4).
APA	Zhu, Jing,Xin, Ying,Liu, Xiaoliang,Wang, Ying,&Liu, Ying.(2018).Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor- by inhibiting the nuclear factor-kappa B signaling pathway.EXPERIMENTAL AND THERAPEUTIC MEDICINE,15(4).
MLA	Zhu, Jing,et al."Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor- by inhibiting the nuclear factor-kappa B signaling pathway".EXPERIMENTAL AND THERAPEUTIC MEDICINE 15.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。